Prime Medicine Inc.

NASDAQ: PRME · Real-Time Price · USD
3.62
-0.02 (-0.55%)
At close: Aug 15, 2025, 12:50 PM

Prime Medicine Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-52.59M -51.89M -42.28M -52.52M -55.33M -45.76M -65.64M -50.71M -42.38M -39.4M -39.28M -29.35M -29.35M -23.84M -62.91M -16.41M 616K -86.66M
Depreciation & Amortization
1.45M 1.54M 1.72M 1.56M 1.54M 1.31M 1.25M 1.24M 1.12M 1.05M 870K 631K 430K 293K 229K 167K 122K 50K
Stock-Based Compensation
6.33M 5.68M 5.94M 6.83M n/a 5.21M 4.43M 4.22M 3.58M 1.68M 2.57M 1.42M 1.34M 1.12M 1.11M 339K 94K 206K
Other Working Capital
9.52M -9.52M 46.4M 2.06M -1.4M -24.23M 12.17M -3.36M -7.19M 504K 740K -3.45M 185K -35.34M 31.48M -905K -707K 122K
Other Non-Cash Items
-4.25M 3.31M 2M 14.64M 13.18M 15.23M 6.3M 3.8M 2.42M 3.92M 4.16M 840K 6.23M 6.45M 15.58M 9.45M -6.54M 81.41M
Deferred Income Tax
n/a n/a n/a n/a -134K 134K -4.64M -108K 31K -202K -202K 212K -442K -532K 1.24M -2.37M n/a n/a
Change in Working Capital
7.65M -7.65M 48.86M 3.58M -4.75M -30.11M 14.45M 2.4M -5.59M -8.62M 1.17M -3.85M 1.57M -34.29M 31.56M -780K -707K 122K
Operating Cash Flow
-41.41M -48.86M 16.25M -25.91M -45.49M -67.71M -43.86M -39.17M -40.82M -41.56M -30.71M -30.1M -20.22M -50.79M -13.19M -9.61M -6.41M -4.88M
Capital Expenditures
-1.57M -2.42M -1.79M -1.28M -1.9M -2.32M -1.84M -2.91M -1.98M -2M -4.81M -4.79M -4.8M -1.69M -382K -1.82M -926K -1.02M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -43.13K 34.86K n/a 10.67K n/a 8.72K n/a n/a n/a n/a n/a n/a
Purchase of Investments
-6.91M -48.32M 16.87M -10.4M -28.7M -107.21M -4.41M -54.88M 7K -45.67M -33.87M -14.72M -74.74M n/a -139K -5.92M n/a n/a
Sales Maturities Of Investments
11.25M 3M 32.9M 61.3M 37.5M 72.5M 47.53M 20.02M 30M 35M 25M 6M 29.5M 32.5M 13M n/a n/a n/a
Other Investing Acitivies
n/a n/a 276K 724K n/a -34.71M 43.13K -34.86K -170K -10.67K -1K -8.72K -745K 81K -325K 108K -76.25M 46K
Investing Cash Flow
2.77M -47.74M 48.25M 50.34M 6.89M -37.03M 41.28M -37.77M 27.86M -12.66M -13.69M -13.51M -50.79M 30.89M 12.15M -7.64M -77.17M -972K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
197K 6M 1K 432K 35K 25.27M 194K 318K 75K 68K -1.18M -746K -624K -1.27M -1.09M n/a 268.05M 2.31M
Financial Cash Flow
197K 6M 1K 38.51M 35K 157.33M 194K 318K 75K 68K 184.07M -683K -624K -1.27M -1.09M -1K 268.05M 2.31M
Net Cash Flow
-38.44M -90.6M 64.5M 62.94M -38.56M 52.59M -2.38M -76.62M -12.88M -54.16M 139.67M -44.29M -71.64M -21.17M -2.12M -17.24M 184.47M -3.54M
Free Cash Flow
-42.98M -51.28M 14.45M -27.19M -47.39M -70.03M -45.7M -42.08M -42.8M -43.56M -35.53M -34.89M -25.02M -52.48M -13.57M -11.43M -7.34M -5.89M